Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

The Trinity, Ulster and Department of Agriculture Cohort Study (TUDA)

26. januar 2016 oppdatert av: University of Ulster

Background:

Cardiovascular disease (CVD), osteoporosis and dementia are chronic diseases of ageing that impact adversely on the lives of those affected and have major health, social and economic consequences. A number of factors are considered to be implicated in these diseases, ranging from the more established factors to those that are less well recognised. Lifestyle factors such as diet, body weight, smoking, physical activity and years of education are acknowledged as risk factors for the development of these chronic diseases of aging. Emerging research suggests that elevated homocysteine and/or sub-optimal status of the metabolically related B-vitamins (folate, vitamin B12, B6 and riboflavin) may be associated with a higher risk of age-related disease. The interplay between relevant genetic and nutrient factors (gene-nutrient interactions) is considered to be highly relevant in the development (and prevention) of chronic diseases of ageing, however this relatively new area of research is as yet poorly understood. The collection of clinical, lifestyle, nutritional and genetic data on large numbers of patients would permit the investigation of those nutrients which interact with specific genes to increase the likelihood of a person developing chronic diseases of ageing.

Aim:

The aim of the TUDA study is to collect detailed clinical, lifestyle, dietary, genetic and biochemical data to investigate gene-nutrient interactions (particularly from the perspective of the B-vitamins and vitamin D/calcium) in the development of CVD, osteoporosis and dementia by studying older adults exhibiting the early stages of these common diseases, namely hypertension, low bone mineral density, and early memory loss, respectively.

Secondary aim (follow up TUDA investigation):

The aim of this longitudinal investigation is to re-assess clinical, nutritional, genetic and biochemical factors in relation to the progression of disease outcomes in TUDA study participants, in subsequent years after initial investigation.

Study design:

A total of 6000 non-institutionalised older Irish people aged over 60 years with early predictors of either dementia, stroke and osteoporosis (namely early memory loss, high blood pressure and low bone mineral density, respectively) recruited from three centres (St James's Hospital Dublin, Ulster University Coleraine and The Clinical Translational Research and Innovation Centre (C-TRIC), Londonderry) across Ireland. Non-fasting blood samples were collected from all subjects and routine blood biochemistry profiles and biomarkers of relevance to B vitamin and vitamin D status were measured. Supplement use was recorded and a targeted food frequency questionnaire was used to record dietary intakes of specific vitamins of interest (folate, B12, B6, riboflavin and D) from major food sources, particularly fortified foods. Physiological function tests including blood pressure, bone health (DXA scans) and cognitive function tests and anthropometric measures were also taken.

Studieoversikt

Studietype

Observasjonsmessig

Registrering (Faktiske)

5186

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Dublin8
      • Dublin, Dublin8, Irland
        • St James's Hospital
      • Londonderry, Storbritannia, BT47 6SB
        • Clinical Translational Research and Innovation Centre (C-TRIC), Altnagelvin Hospital
    • Londonderry
      • Coleraine, Londonderry, Storbritannia, BT52 1SA
        • Human Intervention Studies Unit, Ulster University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

60 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Patients aged 60 and above

Beskrivelse

Inclusion Criteria:

  • >60 years of age

Exclusion Criteria:

  • <60 years of age
  • Born outside the island of Ireland
  • Severe dementia

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Cross-sectional cohort
Cohort who took part in the cross-sectional study (n=5186)
Cross-sectional cohort + follow-up
Cohort who took part in both the cross-sectional and follow-up study (planned n=500 (on-going))

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Blood pressure
Tidsramme: 10 years
10 years
Bone health (DXA)
Tidsramme: 10 years
Dual energy x ray absorptiometry (DXA) scan
10 years
Cognitive function 1 (MMSE)
Tidsramme: 10 years
Mini-Mental State Examination (MMSE)
10 years
Cognitive function 2 (FAB)
Tidsramme: 10 years
Frontal Assessment Battery (FAB)
10 years
Cognitive function 3 (RBANS)
Tidsramme: 10 years
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
10 years
Anxiety (HADS)
Tidsramme: 10 years
Hospital Anxiety and Depression Scale (HADS)
10 years
Depression (CES-D)
Tidsramme: 10 years
Center for Epidemiologic Studies Depression Scale (CES-D)
10 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Weight
Tidsramme: 10 years
10 years
Routine biochemical markers
Tidsramme: 10 years
Measured in blood
10 years
Vitamin biomarkers
Tidsramme: 10 years
Measured in blood
10 years
Single nucleotide polymorphisms
Tidsramme: 10 years
Measured in DNA sample
10 years
Measures of mobility (TUG)
Tidsramme: 10 years
Timed Up and Go (TUG)
10 years
Measures of muscle strength
Tidsramme: 10 years
Hand grip strength (dynamometer)
10 years
Bone turnover markers
Tidsramme: 10 years
Measured in blood
10 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. desember 2008

Primær fullføring (Forventet)

1. desember 2018

Studiet fullført (Forventet)

1. desember 2018

Datoer for studieregistrering

Først innsendt

14. januar 2016

Først innsendt som oppfylte QC-kriteriene

26. januar 2016

Først lagt ut (Anslag)

27. januar 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

27. januar 2016

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. januar 2016

Sist bekreftet

1. januar 2016

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere